These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 37776412)

  • 1. Immunobiology of cancer stem cells and their immunoevasion mechanisms.
    Marzban H; Pedram N; Amini P; Gholampour Y; Saranjam N; Moradi S; Rahvarian J
    Mol Biol Rep; 2023 Nov; 50(11):9559-9573. PubMed ID: 37776412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer Stem Cells: Devil or Savior-Looking behind the Scenes of Immunotherapy Failure.
    Castagnoli L; De Santis F; Volpari T; Vernieri C; Tagliabue E; Di Nicola M; Pupa SM
    Cells; 2020 Feb; 9(3):. PubMed ID: 32120774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies.
    An J; Hu X; Liu F
    Front Oncol; 2023; 13():1114621. PubMed ID: 36910604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
    Maccalli C; Parmiani G; Ferrone S
    Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis.
    Singh D; Khan MA; Siddique HR
    Biochem Pharmacol; 2022 Apr; 198():114955. PubMed ID: 35181312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.
    Ruiu R; Tarone L; Rolih V; Barutello G; Bolli E; Riccardo F; Cavallo F; Conti L
    Prog Mol Biol Transl Sci; 2019; 164():119-188. PubMed ID: 31383404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs.
    Tomei S; Ibnaof O; Ravindran S; Ferrone S; Maccalli C
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33918136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cancer stem cells in the modulation of anti-tumor immune responses.
    Maccalli C; Rasul KI; Elawad M; Ferrone S
    Semin Cancer Biol; 2018 Dec; 53():189-200. PubMed ID: 30261276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of stem cells in small-cell lung cancer: evidence from chemoresistance to immunotherapy.
    Guo W; Qiao T; Li T
    Semin Cancer Biol; 2022 Dec; 87():160-169. PubMed ID: 36371027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets.
    Müller L; Tunger A; Plesca I; Wehner R; Temme A; Westphal D; Meier F; Bachmann M; Schmitz M
    Front Immunol; 2020; 11():140. PubMed ID: 32117287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of tumor microenvironment on cancer stem cell fate in solid tumors.
    Razi S; Haghparast A; Chodari Khameneh S; Ebrahimi Sadrabadi A; Aziziyan F; Bakhtiyari M; Nabi-Afjadi M; Tarhriz V; Jalili A; Zalpoor H
    Cell Commun Signal; 2023 Jun; 21(1):143. PubMed ID: 37328876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy.
    Dianat-Moghadam H; Mahari A; Salahlou R; Khalili M; Azizi M; Sadeghzadeh H
    Stem Cell Res Ther; 2022 Apr; 13(1):150. PubMed ID: 35395787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
    Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
    Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells.
    Khosravi N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Shahgoli VK; Hemmat N; Safarzadeh E; Baradaran B
    Life Sci; 2020 Sep; 256():118005. PubMed ID: 32593711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells, CD200 and immunoevasion.
    Kawasaki BT; Farrar WL
    Trends Immunol; 2008 Oct; 29(10):464-8. PubMed ID: 18775673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure.
    Galassi C; Musella M; Manduca N; Maccafeo E; Sistigu A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
    Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
    J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting the umbilical cord: Cancer stem cell-targeted therapeutics.
    Banik A; Sharma R; Chauhan A; Singh S
    Life Sci; 2022 Jun; 299():120502. PubMed ID: 35351466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.